Bradykinin and the pathophysiology of angioedema
- 31 March 2003
- journal article
- review article
- Published by Elsevier BV in International Immunopharmacology
- Vol. 3 (3), 311-317
- https://doi.org/10.1016/s1567-5769(02)00162-5
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Examination of baseline levels of carboxypeptidase N and complement components as potential predictors of angioedema associated with the use of an angiotensin-converting enzyme inhibitorArchives of Dermatology, 1997
- Appraisal of the validity of histamine-induced wheal and flare to predict the clinical efficacy of antihistaminesJournal of Allergy and Clinical Immunology, 1997
- Chronic urticaria: Pathophysiology and treatment approachesJournal of Allergy and Clinical Immunology, 1996
- Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: A rationale for prophylactic use of tranexamic acidJournal of Allergy and Clinical Immunology, 1994
- Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activitiesClinical and Experimental Immunology, 1994
- C1 Inhibitor and Hereditary Angioneurotic EdemaAnnual Review of Immunology, 1988
- Prekallikrein Activation and High-Molecular-Weight Kininogen Consumption in Hereditary AngioedemaThe New England Journal of Medicine, 1983
- Detection of active kallikrein in induced blister fluids of hereditary angioedema patients.The Journal of Experimental Medicine, 1980
- Acquired C1 inhibitor deficiency in lymphosarcomaClinical Immunology and Immunopathology, 1972
- Hereditary angioneurotic edema: II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikreinJournal of Allergy, 1962